Skip to main content
Caplight Logo









Seal Rock Therapeutics

Seal Rock Therapeutics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://sealrocktx.com/

Last Round

Grant

Mar 29, 2023

Total Funding Raised

$487,500

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Seal Rock Therapeutics is a biotechnology company that develops small-molecule inhibitors designed to treat inflammatory and fibrotic conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

kinase inhibitorsbiotechnologydrug discoveryASK1 inhibitorclinical-stage biotechsmall-molecule drugsNASH treatmentneurodegenerative diseasebiopharmaout-licensingLRRK2 inhibitorsdrug developmentliver diseasepreclinical researchtherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seal Rock Therapeutics Comparables

Compare Seal Rock Therapeutics with similar companies based on industry and business-model similarity.

Seal Rock Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genfit S.A.
78%
Galmed Pharmaceuticals Ltd.
78%
Hepion Pharmaceuticals Inc
77%

Seal Rock Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 29, 2023
Series AOct 18, 2021
SeedJun 30, 2021
SeedSep 30, 2020

Key People

Founding team and executive leadership

Neil McDonnell

Chief Executive Officer

Executive Team

Artur Plonowski

Chief Scientific Officer

Executive Team

Seal Rock Therapeutics Investors

Notable investors and investment history

Seal Rock Therapeutics investors
InvestorRounds
NIH RADxGrant
National Institute on Alcohol Abuse and AlcoholismGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 215% MoM.

  • Sep 29, 2025

    Added Lights B2B, a technology marketplace startup, as a customer.

Seal Rock Therapeutics Filings

Explore SEC and related filing metadata, where available.

Seal Rock Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Seal Rock Therapeutics's valuation, stock price, and market status.

Is Seal Rock Therapeutics a public or private company?

Seal Rock Therapeutics is a private company.

What is the current stock price of Seal Rock Therapeutics?

Seal Rock Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Seal Rock Therapeutics worth (valuation)?

Valuation information for Seal Rock Therapeutics is not publicly available.

Can I buy Seal Rock Therapeutics stock?

Seal Rock Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Seal Rock Therapeutics's last funding round?

Seal Rock Therapeutics's most recent funding round was Grant on March 29, 2023.

Who are the main investors in Seal Rock Therapeutics?

Key investors in Seal Rock Therapeutics include National Institute on Alcohol Abuse and Alcoholism.

Will Seal Rock Therapeutics IPO soon?

No public IPO plans have been announced for Seal Rock Therapeutics.

How can I track Seal Rock Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seal Rock Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range8
Year Founded2016
Last FundingMar 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?